Skip to main content
Fig. 1 | BMC Medical Genomics

Fig. 1

From: Transcriptome profiling analysis reveals that CXCL2 is involved in anlotinib resistance in human lung cancer cells

Fig. 1

Effect of anlotinib on cytotoxicity on NCI-H1975 cells and anlotinib resistant NCI-H1975 cells. a, b NCI-H1975 cells and anlotinib resistant NCI-H1975 cells were treated with anlotinib (8 μg/ml) for 24 h, and then the cell numbers were captured by phase-contrast microscopy. Scale bar, 50 μm. c, d Cell viabilities were examined when NCI-H1975 cells and anlotinib resistant NCI-H1975 cells were exposed to anlotinib (8 μg/ml) for 24 h. Data are shown as the mean ± SD, n = 3, **P < 0.01

Back to article page